Charlamagne Tha God, multi-media mogul and founder of the Mental Wealth Alliance, is furthering his efforts towards mental…
Month: July 2021
Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio
The global autoimmune disease diagnostics market estimates it to grow by USD 1.98 billion during 2021-2025, with a…
Steven Ginsburg’s Book and Treatment Center Aims to Help Others Out of Addiction
“You are worth it — all of it. You are loved and you have been chosen.…
Youtheory Launches Daily Fat Burner Designed to Promote Healthy Weight Management
Southern California based supplement company Youtheory® has launched its Daily Fat Burner. This supplement is designed…
Post COVID-19 3D Scanners Markets Procurement Research Report
SpendEdge’s latest market research report estimates the 3D Scanners market to grow by USD 2 billion, registering…
Arctic Vision Joins Forces with the University of Hong Kong Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today…
Infinx Partners With Strategic Radiology’s Group Purchasing Program to Offer an AI-Driven Prior Authorization Solution to Members
Infinx Healthcare and Strategic Radiology, a physician-owned consortium of privately held, quality-focused radiology groups, are pleased…
IDEXX Laboratories to Release 2021 Second Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing,…
Intranasal COVID-19 vaccine demonstrates single-dose efficacy in preclinical studies, in parallel with achievement of Phase 1 clinical milestone
Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic virus…
VBI Vaccines Reports New CPT Code Issued for a 3-Antigen Prophylactic Hepatitis B Vaccine
CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the…